AI Briefing#drug-discovery
The latest AI and developer news about #drug-discovery, with the original source and a short summary.
The latest AI and developer news about #drug-discovery, with the original source and a short summary.
OpenAI has launched GPT-Rosalind, a specialized model that accelerates life sciences research and drug design.
GPT-Rosalind has been released as a reasoning model to help with life sciences research and drug development.
Moving past the easy problems AI can solve, the focus of innovation is shifting toward health and longevity.
Customized Amazon Nova models have improved the performance of molecular property prediction for drug discovery.
Anthropic acquired biotech AI startup Coefficient Bio for $400 million, expanding into the healthcare sector.
Roche is expanding its AI infrastructure globally by deploying more than 3,500 NVIDIA Blackwell GPUs to boost drug discovery and manufacturing efficiency.
A community-driven research project is launching to accelerate food allergy research using AI technology.
SandboxAQ has released SAIR, a dataset of 5.24 million 3D protein-ligand structures for predicting drug efficacy.